Catalyst Wire Dossier Catalyst Wire Dossier

Soolantra

ivermectin · Galderma Laboratories, L.P.
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Soolantra, covering 2014-12-19 to 2022-10-14. Get the full timeline:

Most recent: FDA Approved: SOOLANTRA — Supplemental Application (Galderma Laboratories, L.P.)

See pricing